fda warning letter hims compounded semaglutide september 2025 Why the Issued 30 Letters to Telehealth Sites Marketing GLP-1s U.S. FDA sends drug advertising

While certain GLP-1 medications are approved for diabetes and weight loss by the US Food and Drug Administration (FDA), most off-label semaglutide medications are compounded GLP-1s, which are not FDA-approved

Increased levels of glutathione in inflamed joint tissues can help control joint inflammation and alleviate the pain associated with it

This differs from the approved low-dose titration schedules (such as starting semaglutide at 0.25mg) that manufacturers recommend to improve tolerability

This means researchers get peptides quickly with this vendor

Time investment: Extended protocols require sustained commitment beyond initial purchase